Literature DB >> 17347808

Angiographic lesion of polypoidal choroidal vasculopathy on indocyanine green and fluorescein angiography.

Fumi Gomi1, Miki Sawa, Keiichi Mitarai, Motokazu Tsujikawa, Yasuo Tano.   

Abstract

BACKGROUND: Before treating polypoidal choroidal vasculopathy (PCV), the extent of the lesion should be determined, but the angiographic lesion size of PCV is sometimes different when comparing indocyanine green angiography (ICGA) and fluorescein angiography (FA). The purpose of this study was to evaluate angiographic findings and compare the lesion sizes of PCV on ICGA and FA using confocal scanning laser ophthalmoscopy (SLO) and fundus camera.
METHODS: Thirty-seven eyes of 37 patients with PCV were examined by ICGA and FA using confocal SLO and a fundus camera, and the findings and the lesion sizes were compared during the early, mid, and late-phases of ICGA and FA.
RESULTS: The polyps with abnormal vessel networks were depicted on ICGA in all eyes and the lesion showed classic-type leakage on FA in 15 eyes. Ten eyes with a pigment epithelial detachment (PED) had the maximal lesion size on FA because hyperfluorescent areas involving PED were determined as the lesions; although on ICGA, a PED distinguished from abnormal vessels was not included in the lesion. In 27 eyes without a PED, the early-phase of ICGA using confocal SLO showed the maximal lesion size in 24 eyes (89%) and the late-phase in three eyes (11%), and the maximal size on ICGA agreed on FA. While FA depicted the maximal lesion sizes in 24 eyes (89%), another three eyes showed the maximal lesion size on early-phase ICGA on confocal SLO. The maximal lesion size on ICGA using a fundus camera was smaller than when using confocal SLO in seven eyes (19%).
CONCLUSIONS: The ICGA on confocal SLO could visualize the more detailed findings of the abnormal vasculature of PCV and the FA showed hyperfluorescent regions overlaying the lesions. To determine the maximal lesion size on angiograms, early-phase ICGA using confocal SLO and FA should be referred.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17347808     DOI: 10.1007/s00417-007-0564-y

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  21 in total

1.  Optical coherence tomography of idiopathic polypoidal choroidal vasculopathy.

Authors:  H Iijima; M Imai; T Gohdo; S Tsukahara
Journal:  Am J Ophthalmol       Date:  1999-03       Impact factor: 5.258

2.  A study of laser photocoagulation for polypoidal choroidal vasculopathy.

Authors:  Mitsuko Yuzawa; Ryuzaburo Mori; Miho Haruyama
Journal:  Jpn J Ophthalmol       Date:  2003 Jul-Aug       Impact factor: 2.447

3.  The origins of polypoidal choroidal vasculopathy.

Authors:  M Yuzawa; R Mori; A Kawamura
Journal:  Br J Ophthalmol       Date:  2005-05       Impact factor: 4.638

4.  The expanding clinical spectrum of idiopathic polypoidal choroidal vasculopathy.

Authors:  L A Yannuzzi; A Ciardella; R F Spaide; M Rabb; K B Freund; D A Orlock
Journal:  Arch Ophthalmol       Date:  1997-04

5.  Polypoidal choroidal vasculopathy and photodynamic therapy with verteporfin.

Authors:  Rufino M Silva; João Figueira; M Luz Cachulo; Liliane Duarte; José R Faria de Abreu; J G Cunha-Vaz
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2005-10-20       Impact factor: 3.117

6.  Polypoidal choroidal vasculopathy: natural history.

Authors:  Masanobu Uyama; Mitsumasa Wada; Yoshimi Nagai; Takashi Matsubara; Hiroshi Matsunaga; Ichiro Fukushima; Kanji Takahashi; Miyo Matsumura
Journal:  Am J Ophthalmol       Date:  2002-05       Impact factor: 5.258

7.  Optical coherence tomographic findings of idiopathic polypoidal choroidal vasculopathy.

Authors:  T Otsuji; K Takahashi; I Fukushima; M Uyama
Journal:  Ophthalmic Surg Lasers       Date:  2000 May-Jun

8.  Indocyanine green videoangiography of idiopathic polypoidal choroidal vasculopathy.

Authors:  R F Spaide; L A Yannuzzi; J S Slakter; J Sorenson; D A Orlach
Journal:  Retina       Date:  1995       Impact factor: 4.256

9.  Idiopathic polypoidal choroidal vasculopathy of the macula.

Authors:  R S Moorthy; A T Lyon; M F Rabb; R F Spaide; L A Yannuzzi; L M Jampol
Journal:  Ophthalmology       Date:  1998-08       Impact factor: 12.079

10.  Exudative idiopathic polypoidal choroidal vasculopathy and photodynamic therapy with verteporfin.

Authors:  Maddalena Quaranta; Martine Mauget-Faÿsse; Gabriel Coscas
Journal:  Am J Ophthalmol       Date:  2002-08       Impact factor: 5.258

View more
  8 in total

1.  Long-term follow-up of polypoidal choroidal vasculopathy after photodynamic therapy with verteporfin.

Authors:  Kaori Sayanagi; Fumi Gomi; Miki Sawa; Masahito Ohji; Yasuo Tano
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2007-04-17       Impact factor: 3.117

2.  Humphrey perimetry as a predictor of visual improvement after photodynamic therapy.

Authors:  Mitsuhiro Imasawa; Toyoaki Tsumura; Toyohiko Kikuchi; Arata Sekine; Hiroyuki Iijima
Journal:  Jpn J Ophthalmol       Date:  2009-05-31       Impact factor: 2.447

3.  Angiographic features of transgenic mice with increased expression of human serine protease HTRA1 in retinal pigment epithelium.

Authors:  Sandeep Kumar; Zachary Berriochoa; Balamurali K Ambati; Yingbin Fu
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-05-22       Impact factor: 4.799

Review 4.  Idiopathic polypoidal choroidal vasculopathy: a review of literature with clinical update on current management practices.

Authors:  Yamini Sahu; Niharika Chaudhary; Mukesh Joshi; Aastha Gandhi
Journal:  Int Ophthalmol       Date:  2020-10-20       Impact factor: 2.031

Review 5.  Optical coherence tomography for the diagnosis of neovascular age-related macular degeneration: a systematic review.

Authors:  M M Castillo; G Mowatt; N Lois; A Elders; C Fraser; W Amoaku; J M Burr; A J Lotery; C R Ramsay; A Azuara-Blanco
Journal:  Eye (Lond)       Date:  2014-09-19       Impact factor: 3.775

Review 6.  Polypoidal choroidal vasculopathy: Pearls in diagnosis and management.

Authors:  Giridhar Anantharaman; Jay Sheth; Muna Bhende; Raja Narayanan; Sundaram Natarajan; Anand Rajendran; George Manayath; Parveen Sen; Rupak Biswas; Alay Banker; Charu Gupta
Journal:  Indian J Ophthalmol       Date:  2018-07       Impact factor: 1.848

Review 7.  Current management strategy of polypoidal choroidal vasculopathy.

Authors:  Christine P S Ho; Timothy Y Y Lai
Journal:  Indian J Ophthalmol       Date:  2018-12       Impact factor: 1.848

8.  Association Between the Degree of Inclusion of Components Identified on Fluorescein or Indocyanine Green Angiography in Target Spots and Relapse of Exudate in Eyes with Polypoidal Choroidal Vasculopathy and Typical Age-Related Macular Degeneration After Photodynamic Therapy.

Authors:  Izumi Yoshida; Hikari Taniguchi; Masashi Sakamoto; Takatoshi Maeno
Journal:  Clin Ophthalmol       Date:  2021-05-18
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.